Cargando…
Correction to: The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
Autores principales: | Sui, Qihai, Hu, Zhengyang, Jin, Xing, Bian, Yunyi, Liang, Jiaqi, Zhang, Huan, Yang, Huiqiang, Lin, Zongwu, Wang, Qun, Zhan, Cheng, Chen, Zhencong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362601/ https://www.ncbi.nlm.nih.gov/pubmed/37480138 http://dx.doi.org/10.1186/s13578-023-01084-6 |
Ejemplares similares
-
The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
por: Sui, Qihai, et al.
Publicado: (2023) -
Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma
por: Liang, Jiaqi, et al.
Publicado: (2022) -
Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
por: Sui, Qihai, et al.
Publicado: (2022) -
Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I–IIIA non-small cell lung cancer: a propensity-matched analysis
por: Xi, Junjie, et al.
Publicado: (2020) -
Identification of the relationship between single-cell N6-methyladenosine regulators and the infiltrating immune cells in esophageal carcinoma
por: Bian, Yunyi, et al.
Publicado: (2023)